Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 65

    1.

    Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.

    Kirtane AJ, Patel R, O'Shaughnessy C, Overlie P, McLaurin B, Solomon S, Mauri L, Fitzgerald P, Popma JJ, Kandzari DE, Leon MB.

    JACC Cardiovasc Interv. 2009 Oct;2(10):967-76.PMID: 19850257 [PubMed - in process]Related articles

    2.

    Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

    Nikolsky E, Stone GW, Kirtane AJ, Dangas GD, Lansky AJ, McLaurin B, Lincoff AM, Feit F, Moses JW, Fahy M, Manoukian SV, White HD, Ohman EM, Bertrand ME, Cox DA, Mehran R.

    J Am Coll Cardiol. 2009 Sep 29;54(14):1293-302.PMID: 19778672 [PubMed - indexed for MEDLINE]Related articles

    3.

    5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

    Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.

    J Am Coll Cardiol. 2009 Sep 1;54(10):894-902.PMID: 19712798 [PubMed - indexed for MEDLINE]Related articles

    4.

    Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.

    Mehran R, Nikolsky E, Lansky AJ, Kirtane AJ, Kim YH, Feit F, Manoukian S, Moses JW, Ebrahimi R, Ohman EM, White HD, Pocock SJ, Dangas GD, Stone GW.

    JACC Cardiovasc Interv. 2009 Aug;2(8):748-57.PMID: 19695543 [PubMed - indexed for MEDLINE]Related articles

    5.

    Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.

    Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW.

    Circulation. 2009 Jun 30;119(25):3198-206. Epub 2009 Jun 15.PMID: 19528338 [PubMed - indexed for MEDLINE]Related articles

    6.

    Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.

    Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD.

    JACC Cardiovasc Interv. 2009 May;2(5):415-21.PMID: 19463464 [PubMed - in process]Related articles

    7.

    Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.

    Kirtane AJ, Heyman ER, Metzger C, Breall JA, Carrozza JP Jr.

    JACC Cardiovasc Interv. 2008 Apr;1(2):186-91.PMID: 19463299 [PubMed - indexed for MEDLINE]Related articles

    8.

    Value of drug-eluting stents in cardiac transplant recipients.

    Gupta A, Mancini D, Kirtane AJ, Kaple RK, Apfelbaum MA, Kodali SK, Marboe C, Leon MB, Moses JW, Rabbani LE.

    Am J Cardiol. 2009 Mar 1;103(5):659-62. Epub 2009 Jan 12.PMID: 19231329 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery.

    Tsujita K, Maehara A, Mintz GS, Doi H, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Franklin-Bond T, Dasgupta N, Biro S, Dani L, Dangas GD, Mehran R, Kirtane AJ, Lansky AJ, Kreps EM, Collins MB, Stone GW, Moses JW, Leon MB.

    Am J Cardiol. 2008 Dec 15;102(12):1608-13. Epub 2008 Sep 20.PMID: 19064013 [PubMed - indexed for MEDLINE]Related articles

    10.

    Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.

    Solinas E, Dangas G, Kirtane AJ, Lansky AJ, Franklin-Bond T, Boland P, Syros G, Kim YH, Gupta A, Mintz G, Fahy M, Collins M, Kodali S, Stone GW, Moses JW, Leon MB, Mehran R.

    Am J Cardiol. 2008 Aug 1;102(3):311-5. Epub 2008 May 24.PMID: 18638592 [PubMed - indexed for MEDLINE]Related articles

    11.

    CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective.

    Kirtane AJ, Leon MB.

    Nat Clin Pract Cardiovasc Med. 2008 Aug;5(8):448-9. Epub 2008 Jul 1. No abstract available. PMID: 18594550 [PubMed]Related articles

    12.

    Bivalirudin during primary PCI in acute myocardial infarction.

    Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R; HORIZONS-AMI Trial Investigators.

    N Engl J Med. 2008 May 22;358(21):2218-30.PMID: 18499566 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.

    Kirtane AJ, Chieffo A, Magni V, Mehran R, Colombo A, Moses JW.

    Minerva Cardioangiol. 2008 Feb;56(1):43-53. Review.PMID: 18432168 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.

    Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, Dauerman HL, Ryan TJ Jr, Kiernan FJ, Cutlip DE, Ho KK, Gibson CM, Murphy SA, Cohen DJ.

    Am Heart J. 2008 Apr;155(4):654-60. Epub 2008 Feb 21.PMID: 18371472 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.

    Kim YH, Dangas GD, Solinas E, Aoki J, Parise H, Kimura M, Franklin-Bond T, Dasgupta NK, Kirtane AJ, Moussa I, Lansky AJ, Collins M, Stone GW, Leon MB, Moses JW, Mehran R.

    Am J Cardiol. 2008 Mar 15;101(6):801-6. Epub 2008 Jan 18.PMID: 18328844 [PubMed - indexed for MEDLINE]Related articles

    16.

    Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.

    Jeremias A, Ruisi CP, Kirtane AJ, Lee T, Sylvia B, Pinto DS, Ho KK, Cutlip DE, Carrozza JP Jr, Cohen DJ.

    Coron Artery Dis. 2008 Mar;19(2):111-5.PMID: 18300748 [PubMed - indexed for MEDLINE]Related articles

    17.

    Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.

    Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW.

    J Am Coll Cardiol. 2008 Feb 19;51(7):708-15.PMID: 18279734 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction.

    Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, Kissinger KV, Manning WJ, Gibson CM.

    J Thromb Thrombolysis. 2009 Feb;27(2):123-9. Epub 2008 Feb 2.PMID: 18246410 [PubMed - indexed for MEDLINE]Related articles

    19.

    Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study).

    Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, Gibson CM; CLARITY-TIMI 28 Investigators.

    Am J Cardiol. 2008 Feb 1;101(3):303-7. Epub 2007 Dec 20.PMID: 18237589 [PubMed - indexed for MEDLINE]Related articles

    20.

    Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.

    Pucelikova T, Mehran R, Kirtane AJ, Kim YH, Fahy M, Weisz G, Lansky AJ, Moussa I, Gray WA, Collins MB, Kodali SK, Stone GW, Moses JW, Leon MB, Dangas G.

    Am J Cardiol. 2008 Jan 1;101(1):63-8. Epub 2007 Nov 19.PMID: 18157967 [PubMed - indexed for MEDLINE]Related articles

    21.

    Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.

    Aoki J, Kirtane AJ, Dangas GD, Lansky AJ, Morales A, Kimura M, Kim YH, Moussa I, Weisz G, Kreps EM, Collins M, Frankin-Bond T, Stone GW, Moses JW, Leon MB, Mehran R.

    Am J Cardiol. 2008 Jan 1;101(1):58-62. Epub 2007 Nov 26.PMID: 18157966 [PubMed - indexed for MEDLINE]Related articles

    22.

    Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.

    Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E; TIMI Study Group.

    Am Heart J. 2008 Jan;155(1):133-9. Epub 2007 Nov 19.PMID: 18082504 [PubMed - indexed for MEDLINE]Related articles

    23.

    Clinical use of sirolimus-eluting stents.

    Kirtane AJ, Leon MB.

    Cardiovasc Drug Rev. 2007 Winter;25(4):316-32. Review.PMID: 18078432 [PubMed - indexed for MEDLINE]Related articles

    24.

    Gender-specific outcomes after sirolimus-eluting stent implantation.

    Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R.

    J Am Coll Cardiol. 2007 Nov 27;50(22):2111-6. Epub 2007 Nov 13.PMID: 18036446 [PubMed - indexed for MEDLINE]Related articles

    25.

    Temporal changes in TIMI myocardial perfusion grade in relation to epicardial flow, ST-resolution and left ventricular function after primary percutaneous coronary intervention.

    Aasa M, Kirtane AJ, Dellborg M, Gibson MC, Prahl-Abrahamsson U, Svensson L, Grip L.

    Coron Artery Dis. 2007 Nov;18(7):513-8.PMID: 17925603 [PubMed - indexed for MEDLINE]Related articles

    26.

    Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.

    Kumar R, Lee TT, Jeremias A, Ruisi CP, Sylvia B, Magallon J, Kirtane AJ, Bigelow B, Abrahamson M, Pinto DS, Ho KK, Cohen DJ, Carrozza JP Jr, Cutlip DE.

    Am J Cardiol. 2007 Oct 15;100(8):1187-91. Epub 2007 Aug 2.PMID: 17920355 [PubMed - indexed for MEDLINE]Related articles

    27.

    Revascularization in heart failure: the role of percutaneous coronary intervention.

    Kirtane AJ, Moses JW.

    Heart Fail Clin. 2007 Apr;3(2):229-35. Review.PMID: 17643923 [PubMed - indexed for MEDLINE]Related articles

    28.

    Vascular endothelial growth factors in pulmonary edema: an update.

    Kosmidou I, Karmpaliotis D, Kirtane AJ, Barron HV, Gibson CM.

    J Thromb Thrombolysis. 2008 Jun;25(3):259-64. Epub 2007 Jun 7. Review.PMID: 17554593 [PubMed - indexed for MEDLINE]Related articles

    29.

    The Anchor-Tornus technique: a novel approach to "uncrossable" chronic total occlusions.

    Kirtane AJ, Stone GW.

    Catheter Cardiovasc Interv. 2007 Oct 1;70(4):554-7.PMID: 17503510 [PubMed - indexed for MEDLINE]Related articles

    30.

    Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.

    Karmpaliotis D, Kirtane AJ, Ruisi CP, Polonsky T, Malhotra A, Talmor D, Kosmidou I, Jarolim P, de Lemos JA, Sabatine MS, Gibson CM, Morrow D.

    Chest. 2007 Apr;131(4):964-71.PMID: 17426196 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.

    Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, McCabe CH, Gibson CM, Braunwald E.

    Eur Heart J. 2007 Apr;28(7):806-13. Epub 2007 Apr 2.PMID: 17403721 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

    Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB.

    N Engl J Med. 2007 Mar 8;356(10):998-1008. Epub 2007 Feb 12.PMID: 17296824 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Distal embolization of thrombus in acute myocardial infarction.

    Kirtane AJ, Gibson CM.

    Am J Med. 2006 Dec;119(12):e1-2. No abstract available. PMID: 17145234 [PubMed - indexed for MEDLINE]Related articles

    34.

    Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.

    Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP Jr, Antman EM, Cannon CP, Gibson CM.

    Circulation. 2006 Nov 7;114(19):2019-25. Epub 2006 Oct 30.PMID: 17075010 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial.

    Gibson CM, Kirtane AJ, Murphy SA, Rohrbeck S, Menon V, Lins J, Kazziha S, Rokos I, Shammas NW, Palabrica TM, Fish P, McCabe CH, Braunwald E; TIMI Study Group.

    Am Heart J. 2006 Oct;152(4):668-75.PMID: 16996831 [PubMed - indexed for MEDLINE]Related articles

    37.

    Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS.

    Ray KK, Bach RG, Cannon CP, Cairns R, Kirtane AJ, Wiviott SD, McCabe CH, Braunwald E, Gibson CM; PROVE IT-TIMI 22 Investigators.

    Eur Heart J. 2006 Oct;27(19):2310-6. Epub 2006 Aug 3.PMID: 16887854 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy.

    Kirtane AJ, Vafai JJ, Murphy SA, Aroesty JM, Sabatine MS, Cannon CP, Gibson CM; TIMI Study Group.

    Eur Heart J. 2006 Sep;27(17):2040-5. Epub 2006 Jul 17.PMID: 16847010 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina.

    Deibele AJ, Kirtane AJ, Pinto DS, Lucca MJ, Neva C, Shui A, Murphy SA, Tcheng JE, Gibson CM.

    J Thromb Thrombolysis. 2006 Aug;22(1):47-50.PMID: 16786232 [PubMed - indexed for MEDLINE]Related articles

    40.

    Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials).

    Ly HQ, Kirtane AJ, Murphy SA, Buros J, Cannon CP, Braunwald E, Gibson CM; TIMI Study Group.

    Am J Cardiol. 2006 Jul 1;98(1):1-5. Epub 2006 Apr 27.PMID: 16784909 [PubMed - indexed for MEDLINE]Related articles

    41.

    Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.

    Kirtane AJ, Piazza G, Murphy SA, Budiu D, Morrow DA, Cohen DJ, Peterson E, Lakkis N, Herrmann HC, Palabrica TM, Gibson CM; TIMI Study Group.

    J Am Coll Cardiol. 2006 Jun 20;47(12):2374-9. Epub 2006 May 30.PMID: 16781361 [PubMed - indexed for MEDLINE]Related articles

    42.

    Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.

    Gibson CM, Karmpaliotis D, Kosmidou I, Murphy SA, Kirtane AJ, Budiu D, Ray KK, Herrmann HC, Lakkis N, Kovach R, French W, Blankenship J, Lui HH, Palabrica T, Jennings LK, Cohen DJ, Morrow DA; TIMI Study Group.

    Am J Cardiol. 2006 May 15;97(10):1473-7. Epub 2006 Mar 29.PMID: 16679086 [PubMed - indexed for MEDLINE]Related articles

    43.

    Adherence to American College of Cardiology/American Heart Association guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures.

    Kirtane AJ, Rahman AM, Martinezclark P, Jeremias A, Seto TB, Manning WJ.

    Am J Cardiol. 2006 Mar 15;97(6):891-3. Epub 2006 Feb 2.PMID: 16516596 [PubMed - indexed for MEDLINE]Related articles

    44.

    Administration of intracoronary eptifibatide during ST-elevation myocardial infarction.

    Pinto DS, Kirtane AJ, Ruocco NA, Deibele AJ, Shui A, Buros J, Murphy SA, Gibson CM.

    Am J Cardiol. 2005 Dec 1;96(11):1494-7. Epub 2005 Oct 17.PMID: 16310428 [PubMed - indexed for MEDLINE]Related articles

    45.

    Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.

    Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, McCabe CH, Skene AM, Gibson CM, Ridker PM, Braunwald E; PROVE IT-TIMI 22 Investigators.

    J Am Coll Cardiol. 2005 Oct 18;46(8):1417-24.PMID: 16226164 [PubMed - indexed for MEDLINE]Related articles

    46.

    C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial).

    Moghbeli N, Kirtane AJ, Ray KK, Murphy SA, Gibson CM, Braunwald E, Cannon CP; TIMI Study Group.

    Am J Cardiol. 2005 Sep 1;96(5):635-8.PMID: 16125484 [PubMed - indexed for MEDLINE]Related articles

    47.

    U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.

    Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, Cannon CP, Braunwald E, Gibson CM; TIMI Study Group.

    J Am Coll Cardiol. 2005 Jul 5;46(1):178-80. No abstract available. PMID: 15992655 [PubMed - indexed for MEDLINE]Related articles

    48.

    Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates.

    Kirtane AJ, Leder DM, Waikar SS, Chertow GM, Ray KK, Pinto DS, Karmpaliotis D, Burger AJ, Murphy SA, Cannon CP, Braunwald E, Gibson CM; TIMI Study Group.

    J Am Coll Cardiol. 2005 Jun 7;45(11):1781-6.PMID: 15936606 [PubMed - indexed for MEDLINE]Related articles

    49.

    Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.

    Gibson CM, Kirtane AJ, Boundy K, Ly H, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E; TIMI Study Group.

    J Am Coll Cardiol. 2005 Feb 1;45(3):357-62.PMID: 15680712 [PubMed - indexed for MEDLINE]Related articles

    50.

    Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction.

    Ly HQ, Kirtane AJ, Buros J, Giugliano RP, Popma JJ, Antman EM, Harrington RA, Ohman EM, Gibson CM; TIMI Study Group.

    Am J Cardiol. 2005 Feb 1;95(3):383-6.PMID: 15670549 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...